US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LMP Capital and Income Fund Inc

14.95

+0.07000.47%

Volume:16.92K

Turnover:252.19K

Market Cap:341.72M

PE:2.94

High:15.23

Open:14.94

Low:14.60

Close:14.88

52wk High:16.89

52wk Low:13.35

Shares:22.86M

Float Shares:22.86M

Volume Ratio:0.40

T/O Rate:0.07%

Dividend:1.44

Dividend Rate:9.63%

EPS(TTM):5.09

EPS(LYR):-0.0358

ROE:-0.24%

ROA:1.12%

PB:0.90

PE(LYR):-417.53

Loading ...

Overview Company News Filings

Press Release: LMP Capital and Income Fund Inc. (SCD or "the Fund"; CUSIP: 50208A102) Announces Notification of Sources of Distributions

SeaStar Medical Announces 1-for-10 Reverse Split

Vertex's Gene Therapy Works In Children With Blood Disorders

Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting

Fulcrum Therapeutics to Host Investor Event to Review New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease on December 7, 2025

SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

LMP Capital and Income Fund Declares November Distribution with Majority from Long-Term Capital Gains

Press Release: LMP Capital and Income Fund Inc. (SCD or "the Fund"; CUSIP: 50208A102) Announces Notification of Sources of Distributions

Press Release: BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update

SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference

Press Release: SeaStar Medical Announces Appointment of Michael Messinger as CFO

Press Release: Emmaus Life Sciences Reports Quarterly Financial Results

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results

SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025

Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition

Press Release: LMP Capital and Income Fund Inc. (SCD or "the Fund"; CUSIP: 50208A102) Announces Notification of Sources of Distributions

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2025

LMP Capital and Income Fund Inc. Releases Notification of Sources of Distributions Report

SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SCD/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SCD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCD\",,,,,undefined,":{"symbol":"SCD","market":"US","secType":"STK","nameCN":"LMP Capital and Income Fund Inc","latestPrice":14.95,"timestamp":1774468800000,"preClose":14.88,"halted":0,"volume":16917,"delay":0,"changeRate":0.004704301075268717,"floatShares":22857660,"shares":22857660,"eps":5.09,"marketStatus":"Pre-Mkt","change":0.07,"latestTime":"03-26 07:35:29 EDT","open":14.94,"high":15.23,"low":14.6001,"amount":252189.855722,"amplitude":0.042332,"askPrice":15.57,"askSize":330,"bidPrice":13.77,"bidSize":2,"shortable":3,"etf":0,"ttmEps":5.09,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774531800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":14.95,"dividendRate":0.096301,"postHourTrading":{"tag":"盘后","latestPrice":14.95,"preClose":14.95,"latestTime":"16:10 EDT","volume":20,"amount":300.98,"timestamp":1774469405216,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.3980896232875022},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCD\",,,,,undefined,":{"symbol":"SCD","floatShares":22857660,"roa":"1.12%","roe":"-0.24%","lyrEps":-0.035806,"volumeRatio":0.3980896232875022,"shares":22857660,"dividePrice":1.4397,"high":15.23,"amplitude":0.042332,"preClose":14.88,"low":14.6001,"week52Low":13.35,"pbRate":"0.90","psRate":"29.29","week52High":16.89,"institutionHeld":0.4274,"latestPrice":14.95,"committee":-0.987952,"eps":5.09,"divideRate":0.096301,"volume":16917,"delay":0,"ttmEps":5.09,"open":14.94,"prevYearClose":14.81,"prevWeekClose":14.71,"prevMonthClose":15.93,"prevQuarterClose":14.81,"fiveDayClose":15.01,"twentyDayClose":15.91,"sixtyDayClose":14.78,"dividendPayoutRate":0.26655632230905396,"dividendFrequency":"M","dividendGrowthYears":2,"dividendGrowthRate":0.04646017699115057,"fiveYearAvgDividendRate":0.12474605069697212},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SCD\",params:#limit:5,,,undefined,":[{"date":"2026-05-21","symbol":"SCD","amount":0.12,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-05-21","defaultRemindTime":1779370200000,"name":"LMP Capital & Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-29","payableDate":"2026-05-21","currency":"USD","dateTimestamp":1779336000000,"payDate":"2026-05-29"},{"date":"2026-04-23","symbol":"SCD","amount":0.12,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-23","defaultRemindTime":1776951000000,"name":"LMP Capital & Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-30","payableDate":"2026-04-23","currency":"USD","dateTimestamp":1776916800000,"payDate":"2026-04-30"},{"date":"2026-03-24","symbol":"SCD","amount":0.12,"announcedDate":"2026-02-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"LMP Capital & Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2026-02-20","symbol":"SCD","amount":0.12,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-20","defaultRemindTime":1771597800000,"name":"LMP Capital & Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-27","payableDate":"2026-02-20","currency":"USD","dateTimestamp":1771563600000,"payDate":"2026-02-27"},{"date":"2026-01-23","symbol":"SCD","amount":0.12,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-23","defaultRemindTime":1769178600000,"name":"LMP Capital & Income Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-30","payableDate":"2026-01-23","currency":"USD","dateTimestamp":1769144400000,"payDate":"2026-01-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SCD\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-15","recordDate":"2016-06-17","paymentDate":"2016-06-24","value":0.31,"currency":"USD"},{"executeDate":"2016-09-21","recordDate":"2016-09-23","paymentDate":"2016-09-30","value":0.31,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.31,"currency":"USD"},{"executeDate":"2017-03-22","recordDate":"2017-03-24","paymentDate":"2017-04-03","value":0.31,"currency":"USD"},{"executeDate":"2017-06-21","recordDate":"2017-06-23","paymentDate":"2017-07-03","value":0.31,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SCD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SCD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SCD","date":"2026-03-25","current":2.937132,"percent":0.029605,"low":-448.456166,"twenty":-21.272993,"median":2.898652,"eighty":4.797477,"high":18.396706,"avg":-19.063197,"sd":79.205143,"marketCap":340846279},"quantilePoints":[{"date":"2021-03-26","current":-10.06382,"twenty":-5.337169,"median":8.507985,"eighty":89.994993,"marketCap":225057632},{"date":"2021-04-01","current":-10.272646,"twenty":-5.356686,"median":8.507985,"eighty":89.994993,"marketCap":229727623},{"date":"2021-04-09","current":-10.505568,"twenty":-5.387589,"median":8.507985,"eighty":90.097979,"marketCap":234936459},{"date":"2021-04-16","current":-10.690299,"twenty":-5.391655,"median":8.507985,"eighty":90.097979,"marketCap":239067604},{"date":"2021-04-23","current":-10.674235,"twenty":-5.414425,"median":8.507985,"eighty":90.097979,"marketCap":238708374},{"date":"2021-04-30","current":-10.794712,"twenty":-5.459966,"median":8.507985,"eighty":90.097979,"marketCap":241402600},{"date":"2021-05-07","current":-10.931252,"twenty":-5.477043,"median":8.507985,"eighty":90.097979,"marketCap":244456055},{"date":"2021-05-14","current":-10.794712,"twenty":-5.499813,"median":8.507985,"eighty":90.097979,"marketCap":241402600},{"date":"2021-05-21","current":-11.027634,"twenty":-5.52177,"median":8.507985,"eighty":90.097979,"marketCap":246611436},{"date":"2021-05-28","current":-11.308746,"twenty":-5.539661,"median":8.507985,"eighty":90.097979,"marketCap":252897962},{"date":"2021-06-04","current":-11.549699,"twenty":-5.555112,"median":8.507985,"eighty":90.097979,"marketCap":258286413},{"date":"2021-06-11","current":-11.935225,"twenty":-5.57463,"median":8.507985,"eighty":90.097979,"marketCap":266907934},{"date":"2021-06-18","current":-11.493477,"twenty":-5.582762,"median":8.507985,"eighty":90.097979,"marketCap":257029107},{"date":"2021-06-25","current":-11.477413,"twenty":-5.590894,"median":8.507985,"eighty":90.097979,"marketCap":256669877},{"date":"2021-07-02","current":-11.738446,"twenty":-5.608785,"median":8.507985,"eighty":90.097979,"marketCap":262507366},{"date":"2021-07-09","current":-11.68624,"twenty":-5.619357,"median":8.507985,"eighty":90.097979,"marketCap":261339868},{"date":"2021-07-16","current":-11.405127,"twenty":-5.629115,"median":8.507985,"eighty":90.097979,"marketCap":255053342},{"date":"2021-07-23","current":-11.501509,"twenty":-5.673826,"median":8.507985,"eighty":90.097979,"marketCap":257208722},{"date":"2021-07-30","current":2.940516,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":256131032},{"date":"2021-08-06","current":2.946703,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":256669877},{"date":"2021-08-13","current":2.992068,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":260621408},{"date":"2021-08-20","current":2.901337,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":252718347},{"date":"2021-08-27","current":3.008565,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":262058328},{"date":"2021-09-03","current":3.045682,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":265291399},{"date":"2021-09-10","current":2.997966,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":261135107},{"date":"2021-09-17","current":2.946703,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":256669877},{"date":"2021-09-24","current":2.86422,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":249485276},{"date":"2021-10-01","current":2.855971,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":248766816},{"date":"2021-10-08","current":2.901337,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":252718347},{"date":"2021-10-15","current":2.963199,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":258106798},{"date":"2021-10-22","current":3.035372,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":264393324},{"date":"2021-10-29","current":3.039496,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":264752554},{"date":"2021-11-05","current":3.066303,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":267087549},{"date":"2021-11-12","current":3.082799,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":268524469},{"date":"2021-11-19","current":3.041558,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":264932169},{"date":"2021-11-26","current":2.98382,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":259902948},{"date":"2021-12-03","current":2.897213,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":252359117},{"date":"2021-12-10","current":2.992068,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":260621408},{"date":"2021-12-17","current":2.981758,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":259723333},{"date":"2021-12-23","current":3.004441,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":261699098},{"date":"2021-12-31","current":3.134351,"twenty":-9.247434,"median":8.507985,"eighty":90.097979,"marketCap":273014845},{"date":"2022-01-07","current":3.084862,"twenty":-9.236022,"median":8.507985,"eighty":89.994993,"marketCap":268704084},{"date":"2022-01-14","current":3.047744,"twenty":-9.236022,"median":8.507985,"eighty":89.994993,"marketCap":265471014},{"date":"2022-01-21","current":2.876592,"twenty":-9.236022,"median":8.507985,"eighty":89.994993,"marketCap":250562966},{"date":"2022-01-28","current":2.907523,"twenty":-9.236022,"median":8.45586,"eighty":89.994993,"marketCap":253257192},{"date":"2022-02-04","current":3.014751,"twenty":-9.236022,"median":8.432693,"eighty":89.994993,"marketCap":262597173},{"date":"2022-02-11","current":2.942579,"twenty":-9.236022,"median":8.412422,"eighty":89.994993,"marketCap":256310647},{"date":"2022-02-18","current":2.921958,"twenty":-9.236022,"median":8.392152,"eighty":89.994993,"marketCap":254514497},{"date":"2022-02-25","current":2.913709,"twenty":-9.236022,"median":8.374777,"eighty":89.994993,"marketCap":253796037},{"date":"2022-03-04","current":2.882049,"twenty":-9.236022,"median":8.366089,"eighty":89.994993,"marketCap":251038288},{"date":"2022-03-11","current":2.817511,"twenty":-9.236022,"median":8.345818,"eighty":89.994993,"marketCap":245416717},{"date":"2022-03-18","current":2.914318,"twenty":-9.236022,"median":8.325547,"eighty":89.994993,"marketCap":253849074},{"date":"2022-03-25","current":2.884066,"twenty":-9.236022,"median":8.30238,"eighty":89.994993,"marketCap":251213963},{"date":"2022-04-01","current":2.972806,"twenty":-9.236022,"median":8.287901,"eighty":89.994993,"marketCap":258943623},{"date":"2022-04-08","current":2.884066,"twenty":-9.236022,"median":8.270526,"eighty":89.994993,"marketCap":251213963},{"date":"2022-04-14","current":2.851797,"twenty":-9.236022,"median":8.235776,"eighty":89.994993,"marketCap":248403177},{"date":"2022-04-22","current":2.851797,"twenty":-9.236022,"median":8.209598,"eighty":89.994993,"marketCap":248403177},{"date":"2022-04-29","current":2.682383,"twenty":-9.236022,"median":8.189443,"eighty":89.994993,"marketCap":233646553},{"date":"2022-05-06","current":2.734821,"twenty":-9.236022,"median":8.180755,"eighty":89.994993,"marketCap":238214079},{"date":"2022-05-13","current":2.625912,"twenty":-9.236022,"median":8.166276,"eighty":89.994993,"marketCap":228727678},{"date":"2022-05-20","current":2.60776,"twenty":-9.236022,"median":8.151797,"eighty":89.994993,"marketCap":227146611},{"date":"2022-05-27","current":2.797342,"twenty":-9.236022,"median":8.105463,"eighty":89.994993,"marketCap":243659976},{"date":"2022-06-03","current":2.823561,"twenty":-9.236022,"median":8.073609,"eighty":89.994993,"marketCap":245943740},{"date":"2022-06-10","current":2.732804,"twenty":-9.236022,"median":8.053338,"eighty":89.994993,"marketCap":238038405},{"date":"2022-06-17","current":2.404061,"twenty":-9.236022,"median":8.021484,"eighty":89.994993,"marketCap":209403527},{"date":"2022-06-24","current":2.500868,"twenty":-9.247434,"median":8.004109,"eighty":90.097979,"marketCap":217835884},{"date":"2022-07-01","current":2.517003,"twenty":-9.247434,"median":7.980942,"eighty":90.097979,"marketCap":219241276},{"date":"2022-07-08","current":2.537171,"twenty":-9.247434,"median":7.969359,"eighty":90.097979,"marketCap":220998017},{"date":"2022-07-15","current":2.535154,"twenty":-9.247434,"median":7.957775,"eighty":90.097979,"marketCap":220822343},{"date":"2022-07-22","current":2.595659,"twenty":-9.247434,"median":7.934609,"eighty":90.097979,"marketCap":226092566},{"date":"2022-07-29","current":2.704568,"twenty":-9.247434,"median":6.088551,"eighty":90.097979,"marketCap":235578968},{"date":"2022-08-05","current":2.688433,"twenty":-9.247434,"median":6.007831,"eighty":90.097979,"marketCap":234173575},{"date":"2022-08-12","current":2.785241,"twenty":-9.247434,"median":5.973237,"eighty":90.097979,"marketCap":242605932},{"date":"2022-08-19","current":2.785241,"twenty":-9.247434,"median":5.900205,"eighty":90.097979,"marketCap":242605932},{"date":"2022-08-26","current":2.696501,"twenty":-9.247434,"median":5.312107,"eighty":90.097979,"marketCap":234876271},{"date":"2022-09-02","current":2.573474,"twenty":-9.247434,"median":4.989229,"eighty":90.097979,"marketCap":224160151},{"date":"2022-09-09","current":2.654147,"twenty":-9.247434,"median":4.262754,"eighty":90.097979,"marketCap":231187115},{"date":"2022-09-16","current":2.573474,"twenty":-9.247434,"median":4.089784,"eighty":90.097979,"marketCap":224160151},{"date":"2022-09-23","current":2.31532,"twenty":-9.247434,"median":4.043659,"eighty":90.097979,"marketCap":201673866},{"date":"2022-09-30","current":2.272967,"twenty":-9.247434,"median":3.99369,"eighty":90.097979,"marketCap":197984710},{"date":"2022-10-07","current":2.291118,"twenty":-9.247434,"median":3.951408,"eighty":90.097979,"marketCap":199565777},{"date":"2022-10-14","current":2.268933,"twenty":-9.247434,"median":3.905283,"eighty":90.097979,"marketCap":197633362},{"date":"2022-10-21","current":2.333472,"twenty":-9.247434,"median":3.889907,"eighty":90.097979,"marketCap":203254933},{"date":"2022-10-28","current":2.450448,"twenty":-9.247434,"median":3.870689,"eighty":90.097979,"marketCap":213444031},{"date":"2022-11-04","current":2.429271,"twenty":-9.247434,"median":3.839938,"eighty":90.097979,"marketCap":211599453},{"date":"2022-11-11","current":2.581542,"twenty":-9.247434,"median":3.813032,"eighty":90.097979,"marketCap":224862848},{"date":"2022-11-18","current":2.559356,"twenty":-9.247434,"median":3.751531,"eighty":90.097979,"marketCap":222930432},{"date":"2022-11-25","current":2.597676,"twenty":-9.247434,"median":3.716937,"eighty":90.097979,"marketCap":226268240},{"date":"2022-12-02","current":2.585575,"twenty":-9.247434,"median":3.663124,"eighty":90.097979,"marketCap":225214196},{"date":"2022-12-09","current":2.4807,"twenty":-9.247434,"median":3.58671,"eighty":90.097979,"marketCap":216079143},{"date":"2022-12-16","current":2.460532,"twenty":-9.247434,"median":3.555498,"eighty":90.097979,"marketCap":214322402},{"date":"2022-12-23","current":2.381875,"twenty":-9.247434,"median":3.490154,"eighty":90.097979,"marketCap":207471112},{"date":"2022-12-30","current":2.428263,"twenty":-9.247434,"median":3.309496,"eighty":90.097979,"marketCap":211511616},{"date":"2023-01-06","current":2.420195,"twenty":-9.247434,"median":3.134351,"eighty":90.097979,"marketCap":210808920},{"date":"2023-01-13","current":2.537171,"twenty":-9.247434,"median":3.098088,"eighty":90.097979,"marketCap":220998017},{"date":"2023-01-20","current":2.484734,"twenty":-9.247434,"median":3.084862,"eighty":90.097979,"marketCap":216430491},{"date":"2023-01-27","current":2.535154,"twenty":-9.247434,"median":3.080737,"eighty":90.097979,"marketCap":220822343},{"date":"2023-02-03","current":-73.781452,"twenty":-9.441436,"median":3.070427,"eighty":90.097979,"marketCap":223633129},{"date":"2023-02-10","current":-73.607575,"twenty":-9.615782,"median":3.064241,"eighty":90.097979,"marketCap":223106107},{"date":"2023-02-17","current":-73.549616,"twenty":-9.666828,"median":3.055993,"eighty":90.097979,"marketCap":222930432},{"date":"2023-02-24","current":-71.289227,"twenty":-9.690595,"median":3.049806,"eighty":90.097979,"marketCap":216079143},{"date":"2023-03-03","current":-72.738194,"twenty":-9.745753,"median":3.04362,"eighty":90.097979,"marketCap":220470995},{"date":"2023-03-10","current":-69.376589,"twenty":-9.806616,"median":3.039496,"eighty":90.097979,"marketCap":210281897},{"date":"2023-03-17","current":-67.695786,"twenty":-9.852264,"median":3.025061,"eighty":90.097979,"marketCap":205187348},{"date":"2023-03-24","current":-66.826405,"twenty":-9.868605,"median":3.014751,"eighty":90.097979,"marketCap":202552237},{"date":"2023-03-31","current":-70.767598,"twenty":-9.889524,"median":3.009081,"eighty":89.994993,"marketCap":214498076},{"date":"2023-04-06","current":-69.666382,"twenty":-9.905569,"median":3.008565,"eighty":90.30395,"marketCap":211160268},{"date":"2023-04-19","current":-72.622277,"twenty":-9.923821,"median":3.000317,"eighty":90.612908,"marketCap":220119647},{"date":"2023-04-28","current":-70.477804,"twenty":-9.947385,"median":2.994306,"eighty":90.81888,"marketCap":213619705},{"date":"2023-05-05","current":-68.507208,"twenty":-9.985022,"median":2.990006,"eighty":90.81888,"marketCap":207646786},{"date":"2023-05-12","current":-69.724341,"twenty":-9.994912,"median":2.985882,"eighty":90.81888,"marketCap":211335942},{"date":"2023-05-19","current":-70.65168,"twenty":-10.046106,"median":2.981758,"eighty":90.81888,"marketCap":214146727},{"date":"2023-05-26","current":-69.492506,"twenty":-10.086379,"median":2.97351,"eighty":90.81888,"marketCap":210633245},{"date":"2023-06-02","current":-69.898217,"twenty":-10.114737,"median":2.967323,"eighty":90.81888,"marketCap":211862964},{"date":"2023-06-09","current":-71.984731,"twenty":-10.155699,"median":2.961137,"eighty":90.81888,"marketCap":218187232},{"date":"2023-06-16","current":-73.72813,"twenty":-10.198754,"median":2.952889,"eighty":90.81888,"marketCap":223471509},{"date":"2023-06-23","current":-72.04269,"twenty":-10.25168,"median":2.947653,"eighty":90.921866,"marketCap":218362906},{"date":"2023-06-30","current":-72.680236,"twenty":-10.270699,"median":2.944641,"eighty":90.951291,"marketCap":220295321},{"date":"2023-07-07","current":-71.694937,"twenty":-10.28097,"median":2.940516,"eighty":90.951291,"marketCap":217308861},{"date":"2023-07-14","current":-73.897369,"twenty":-10.318249,"median":2.932268,"eighty":90.951291,"marketCap":223984477},{"date":"2023-07-20","current":-74.882667,"twenty":-10.336901,"median":2.919896,"eighty":90.951291,"marketCap":226970937},{"date":"2023-07-28","current":-73.955328,"twenty":-10.373407,"median":2.915045,"eighty":90.097979,"marketCap":224160151},{"date":"2023-08-04","current":-21.900189,"twenty":-10.41739,"median":2.903399,"eighty":16.981542,"marketCap":223281781},{"date":"2023-08-11","current":-22.055265,"twenty":-10.473441,"median":2.901337,"eighty":16.844419,"marketCap":224862848},{"date":"2023-08-18","current":-22.072496,"twenty":-10.502916,"median":2.898184,"eighty":16.694236,"marketCap":225038522},{"date":"2023-08-25","current":-22.313725,"twenty":-10.566513,"median":2.891027,"eighty":16.544053,"marketCap":227497959},{"date":"2023-09-01","current":-22.882338,"twenty":-10.63247,"median":2.882837,"eighty":16.443931,"marketCap":233295204},{"date":"2023-09-08","current":-22.67557,"twenty":-10.683175,"median":2.880716,"eighty":16.319867,"marketCap":231187115},{"date":"2023-09-15","current":-22.244803,"twenty":-10.736884,"median":2.86422,"eighty":15.971617,"marketCap":226795263},{"date":"2023-09-22","current":-21.641729,"twenty":-10.809272,"median":2.8559,"eighty":15.823611,"marketCap":220646669},{"date":"2023-09-29","current":-21.15927,"twenty":-10.841294,"median":2.84978,"eighty":15.76702,"marketCap":215727794},{"date":"2023-10-06","current":-20.556197,"twenty":-10.858966,"median":2.844673,"eighty":15.730018,"marketCap":209579201},{"date":"2023-10-13","current":-21.176501,"twenty":-10.942973,"median":2.837413,"eighty":15.682134,"marketCap":215903468},{"date":"2023-10-20","current":-21.538345,"twenty":-11.00106,"median":2.831227,"eighty":15.636426,"marketCap":219592625},{"date":"2023-10-27","current":-19.901431,"twenty":-11.016276,"median":2.825578,"eighty":15.595072,"marketCap":202903585},{"date":"2023-11-03","current":-21.004194,"twenty":-11.082846,"median":2.817511,"eighty":15.534128,"marketCap":214146727},{"date":"2023-11-10","current":-20.590658,"twenty":-11.117081,"median":2.795325,"eighty":15.431829,"marketCap":209930549},{"date":"2023-11-17","current":-21.831267,"twenty":-11.164174,"median":2.785241,"eighty":15.34912,"marketCap":222579084},{"date":"2023-11-24","current":-22.244803,"twenty":-11.204054,"median":2.762048,"eighty":15.281647,"marketCap":226795263},{"date":"2023-12-01","current":-22.67557,"twenty":-11.254024,"median":2.732804,"eighty":15.148876,"marketCap":231187115},{"date":"2023-12-08","current":-22.589416,"twenty":-11.310355,"median":2.726754,"eighty":15.090109,"marketCap":230308745},{"date":"2023-12-15","current":-23.347566,"twenty":-11.356937,"median":2.704568,"eighty":15.022635,"marketCap":238038405},{"date":"2023-12-22","current":-23.881717,"twenty":-11.397096,"median":2.696501,"eighty":14.979104,"marketCap":243484302},{"date":"2023-12-29","current":-24.191869,"twenty":-11.411888,"median":2.69045,"eighty":14.913807,"marketCap":246646436},{"date":"2024-01-05","current":-23.881717,"twenty":-11.451962,"median":2.683391,"eighty":14.85504,"marketCap":243484302},{"date":"2024-01-12","current":-23.674949,"twenty":-11.477413,"median":2.65919,"eighty":14.800626,"marketCap":241376213},{"date":"2024-01-19","current":-23.45095,"twenty":-11.499903,"median":2.642046,"eighty":14.713563,"marketCap":239092450},{"date":"2024-01-26","current":-23.778333,"twenty":-11.543274,"median":2.622886,"eighty":14.58297,"marketCap":242430258},{"date":"2024-02-02","current":9.626529,"twenty":-11.568976,"median":2.616836,"eighty":14.349599,"marketCap":243659976},{"date":"2024-02-09","current":9.869448,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":249808570},{"date":"2024-02-16","current":9.834745,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":248930199},{"date":"2024-02-23","current":9.869448,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":249808570},{"date":"2024-03-01","current":9.786162,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":247700481},{"date":"2024-03-08","current":9.756733,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":246955611},{"date":"2024-03-15","current":10.007253,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":253296595},{"date":"2024-03-22","current":10.183294,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":257752421},{"date":"2024-03-28","current":10.460897,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":264778917},{"date":"2024-04-05","current":10.257773,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":259637579},{"date":"2024-04-12","current":10.176523,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":257581043},{"date":"2024-04-19","current":9.763504,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":247126989},{"date":"2024-04-26","current":10.14944,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":256895532},{"date":"2024-05-03","current":10.227304,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":258866378},{"date":"2024-05-10","current":10.413502,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":263579271},{"date":"2024-05-17","current":10.447356,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":264436161},{"date":"2024-05-24","current":10.217148,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":258609311},{"date":"2024-05-31","current":10.095274,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":255524508},{"date":"2024-06-07","current":10.406731,"twenty":-11.56255,"median":2.619861,"eighty":9.679277,"marketCap":263407893},{"date":"2024-06-14","current":10.460897,"twenty":-11.568976,"median":2.616836,"eighty":9.657067,"marketCap":264778917},{"date":"2024-06-21","current":10.359335,"twenty":-11.575401,"median":2.613811,"eighty":9.637634,"marketCap":262208248},{"date":"2024-06-28","current":10.403684,"twenty":-11.588252,"median":2.609777,"eighty":9.622365,"marketCap":263330773},{"date":"2024-07-05","current":10.521834,"twenty":-11.588252,"median":2.609777,"eighty":9.622365,"marketCap":266321318},{"date":"2024-07-12","current":10.494751,"twenty":-11.588252,"median":2.609777,"eighty":9.622365,"marketCap":265635807},{"date":"2024-07-15","current":10.521834,"twenty":-11.588252,"median":2.609777,"eighty":9.622365,"marketCap":266321318},{"date":"2024-08-02","current":4.208455,"twenty":-11.59789,"median":2.60171,"eighty":5.980925,"marketCap":267178208},{"date":"2024-08-09","current":4.170663,"twenty":-11.59789,"median":2.60171,"eighty":5.938643,"marketCap":264778917},{"date":"2024-08-16","current":4.265144,"twenty":-11.59789,"median":2.60171,"eighty":5.362076,"marketCap":270777145},{"date":"2024-08-23","current":4.421713,"twenty":-11.59789,"median":2.60171,"eighty":5.046886,"marketCap":280717065},{"date":"2024-08-30","current":4.421713,"twenty":-11.59789,"median":2.60171,"eighty":4.421713,"marketCap":280717065},{"date":"2024-09-06","current":4.419013,"twenty":-11.59789,"median":2.60171,"eighty":4.408215,"marketCap":280545687},{"date":"2024-09-13","current":4.451407,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":282602223},{"date":"2024-09-20","current":4.753746,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":301796552},{"date":"2024-09-27","current":4.699757,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":298368993},{"date":"2024-10-04","current":4.815833,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":305738244},{"date":"2024-10-11","current":4.664664,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":296141080},{"date":"2024-10-18","current":4.688959,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":297683481},{"date":"2024-10-25","current":4.591778,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":291513875},{"date":"2024-10-31","current":4.53509,"twenty":-11.59789,"median":2.60171,"eighty":4.402816,"marketCap":287914939},{"date":"2024-11-08","current":4.613374,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":292884899},{"date":"2024-11-15","current":4.599877,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":292028009},{"date":"2024-11-22","current":4.670063,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":296483836},{"date":"2024-11-29","current":4.813134,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":305566867},{"date":"2024-12-06","current":4.756445,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":301967930},{"date":"2024-12-13","current":4.678161,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":296997970},{"date":"2024-12-20","current":4.443308,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":282088089},{"date":"2024-12-27","current":4.645768,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":294941434},{"date":"2025-01-03","current":4.605276,"twenty":-11.604315,"median":2.599693,"eighty":4.38554,"marketCap":292370765},{"date":"2025-01-10","current":4.526991,"twenty":-11.610741,"median":2.597676,"eighty":4.379601,"marketCap":287400805},{"date":"2025-01-17","current":4.605276,"twenty":-11.610741,"median":2.597676,"eighty":4.379601,"marketCap":292370765},{"date":"2025-01-24","current":4.769943,"twenty":-11.610741,"median":2.597676,"eighty":4.379601,"marketCap":302824819},{"date":"2025-01-31","current":3.372162,"twenty":-11.610741,"median":2.597676,"eighty":4.349907,"marketCap":294084545},{"date":"2025-02-07","current":3.368232,"twenty":-11.610741,"median":2.597676,"eighty":4.270338,"marketCap":293741789},{"date":"2025-02-14","current":3.374127,"twenty":-11.610741,"median":2.597676,"eighty":4.219659,"marketCap":294255922},{"date":"2025-02-21","current":3.415395,"twenty":-11.610741,"median":2.597676,"eighty":4.178221,"marketCap":297854859},{"date":"2025-02-28","current":3.295129,"twenty":-11.610741,"median":2.597676,"eighty":4.101017,"marketCap":287366529},{"date":"2025-03-07","current":3.155998,"twenty":-11.617166,"median":2.597676,"eighty":4.050578,"marketCap":275232971},{"date":"2025-03-14","current":3.072474,"twenty":-11.617166,"median":2.597676,"eighty":4.019762,"marketCap":267948919},{"date":"2025-03-21","current":3.19042,"twenty":-11.617166,"median":2.602718,"eighty":4.019762,"marketCap":278234866},{"date":"2025-03-28","current":3.143241,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":274120487},{"date":"2025-04-04","current":3.008068,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":262332100},{"date":"2025-04-11","current":2.734909,"twenty":-11.610741,"median":2.605743,"eighty":4.017423,"marketCap":238510000},{"date":"2025-04-17","current":2.844071,"twenty":-11.610741,"median":2.605743,"eighty":4.017423,"marketCap":248030000},{"date":"2025-04-25","current":2.941538,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":256530000},{"date":"2025-05-02","current":2.982474,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":260100000},{"date":"2025-05-09","current":2.966879,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":258740000},{"date":"2025-05-16","current":3.07994,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":268600000},{"date":"2025-05-23","current":3.048751,"twenty":-11.617166,"median":2.604735,"eighty":4.019762,"marketCap":265880000},{"date":"2025-05-30","current":3.081889,"twenty":-11.617166,"median":2.604735,"eighty":4.005123,"marketCap":268770000},{"date":"2025-06-06","current":3.280721,"twenty":-11.617166,"median":2.604735,"eighty":3.951408,"marketCap":286110000},{"date":"2025-06-13","current":3.035105,"twenty":-11.617166,"median":2.604735,"eighty":3.905283,"marketCap":264690000},{"date":"2025-06-20","current":3.084001,"twenty":-11.623592,"median":2.603727,"eighty":3.88837,"marketCap":268954204},{"date":"2025-06-27","current":3.062339,"twenty":-11.623592,"median":2.603727,"eighty":3.873763,"marketCap":267064998},{"date":"2025-07-03","current":3.145051,"twenty":-11.623592,"median":2.603727,"eighty":3.866076,"marketCap":274278330},{"date":"2025-07-11","current":3.085971,"twenty":-11.623592,"median":2.603727,"eighty":3.415002,"marketCap":269125950},{"date":"2025-07-18","current":3.036737,"twenty":-11.623592,"median":2.603727,"eighty":3.373734,"marketCap":264832301},{"date":"2025-07-25","current":2.99735,"twenty":-11.623592,"median":2.603727,"eighty":3.366267,"marketCap":261397381},{"date":"2025-08-01","current":17.519573,"twenty":-11.623592,"median":2.60776,"eighty":3.371376,"marketCap":347455217},{"date":"2025-08-08","current":17.473408,"twenty":-11.623592,"median":2.625912,"eighty":3.411858,"marketCap":346539656},{"date":"2025-08-15","current":17.611903,"twenty":-11.623592,"median":2.64524,"eighty":4.08345,"marketCap":349286338},{"date":"2025-08-22","current":17.646527,"twenty":-11.623592,"median":2.672299,"eighty":4.191719,"marketCap":349973008},{"date":"2025-08-29","current":17.900433,"twenty":-11.623592,"median":2.688433,"eighty":4.310495,"marketCap":355008591},{"date":"2025-09-05","current":17.831186,"twenty":-11.630017,"median":2.696501,"eighty":4.359625,"marketCap":353635250},{"date":"2025-09-12","current":18.038928,"twenty":-11.623592,"median":2.704568,"eighty":4.407135,"marketCap":357755273},{"date":"2025-09-19","current":18.258211,"twenty":-11.623592,"median":2.72272,"eighty":4.421173,"marketCap":362104185},{"date":"2025-09-26","current":17.946598,"twenty":-11.623592,"median":2.732804,"eighty":4.449787,"marketCap":355924152},{"date":"2025-10-03","current":17.877351,"twenty":-11.623592,"median":2.748938,"eighty":4.510795,"marketCap":354550811},{"date":"2025-10-10","current":18.073552,"twenty":-11.623592,"median":2.781208,"eighty":4.53347,"marketCap":358441943},{"date":"2025-10-17","current":17.369537,"twenty":-11.623592,"median":2.785241,"eighty":4.568563,"marketCap":344479645},{"date":"2025-10-24","current":17.381078,"twenty":-11.623592,"median":2.797342,"eighty":4.593938,"marketCap":344708535},{"date":"2025-10-31","current":17.20796,"twenty":-11.623592,"median":2.817511,"eighty":4.605276,"marketCap":341275183},{"date":"2025-11-07","current":17.011759,"twenty":-11.623592,"median":2.82504,"eighty":4.612294,"marketCap":337384051},{"date":"2025-11-14","current":16.942512,"twenty":-11.623592,"median":2.831227,"eighty":4.641448,"marketCap":336010710},{"date":"2025-11-21","current":16.100003,"twenty":-11.623592,"median":2.837413,"eighty":4.661403,"marketCap":319301731},{"date":"2025-11-28","current":16.907888,"twenty":-11.623592,"median":2.839475,"eighty":4.672222,"marketCap":335324040},{"date":"2025-12-05","current":17.219501,"twenty":-11.623592,"median":2.845746,"eighty":4.68302,"marketCap":341504073},{"date":"2025-12-12","current":17.011759,"twenty":-11.623592,"median":2.851868,"eighty":4.693818,"marketCap":337384051},{"date":"2025-12-19","current":16.861724,"twenty":-11.623592,"median":2.857847,"eighty":4.704616,"marketCap":334408479},{"date":"2025-12-26","current":17.173336,"twenty":-11.623592,"median":2.86422,"eighty":4.718653,"marketCap":340588513},{"date":"2026-01-02","current":17.092548,"twenty":-11.623592,"median":2.876592,"eighty":4.726211,"marketCap":338986282},{"date":"2026-01-09","current":17.484949,"twenty":-11.623592,"median":2.884066,"eighty":4.741868,"marketCap":346768546},{"date":"2026-01-16","current":17.750398,"twenty":-11.623592,"median":2.892133,"eighty":4.755905,"marketCap":352033019},{"date":"2026-01-23","current":17.854269,"twenty":-11.623592,"median":2.898184,"eighty":4.785059,"marketCap":354093031},{"date":"2026-01-30","current":-433.386699,"twenty":-11.673389,"median":2.898652,"eighty":4.797477,"marketCap":355466371},{"date":"2026-02-06","current":-434.782021,"twenty":-11.806716,"median":2.898652,"eighty":4.797477,"marketCap":356610822},{"date":"2026-02-13","current":-443.991139,"twenty":-11.89346,"median":2.898652,"eighty":4.797477,"marketCap":364164196},{"date":"2026-02-20","current":-445.665524,"twenty":-19.997923,"median":2.898652,"eighty":4.797477,"marketCap":365537537},{"date":"2026-02-27","current":-444.270203,"twenty":-20.645796,"median":2.898652,"eighty":4.797477,"marketCap":364393086},{"date":"2026-03-06","current":-436.73547,"twenty":-21.000748,"median":2.898652,"eighty":4.797477,"marketCap":358213053},{"date":"2026-03-13","current":-420.828811,"twenty":-21.104132,"median":2.898652,"eighty":4.797477,"marketCap":345166316},{"date":"2026-03-20","current":-417.796,"twenty":-21.217855,"median":2.898652,"eighty":4.797477,"marketCap":342678786},{"date":"2026-03-25","current":-415.561797,"twenty":-21.272993,"median":2.898652,"eighty":4.797477,"marketCap":340846279}],"updateTime":1774522166678},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SCD\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2595719897","title":"Press Release: LMP Capital and Income Fund Inc. (SCD or \"the Fund\"; CUSIP: 50208A102) Announces Notification of Sources of Distributions","url":"https://stock-news.laohu8.com/highlight/detail?id=2595719897","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595719897?lang=en_us&edition=fundamental","pubTime":"2025-12-31 21:00","pubTimestamp":1767186000,"startTime":"0","endTime":"0","summary":"Pursuant to Section 19 of the Investment Company Act of 1940. The Fund's estimated sources of the distribution to be paid on December 31, 2025, and for the fiscal year 2025 year-to-date are as follows:. Distribution  Net Investment  Short-Term Capital  Long-Term Capital  Return of. Cumulative Estimated Allocations fiscal year-to-date as of November 30, 2025, for the fiscal year ending November 30, 2025:. Distribution  Net Investment     Short-Term       Long-Term Capital  Return of. change in net         Annualized       relation to the       Year-To-Date. asset value    Distribution Rate   change in NAV for   Distribution Rate. for the 5- year     (as a percentage   the fiscal period    (as a percentage. period ended on       of NAV as of          through           of NAV as of","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCD","NAV"],"gpt_icon":0},{"id":"2593445522","title":"SeaStar Medical Announces 1-for-10 Reverse Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2593445522","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593445522?lang=en_us&edition=fundamental","pubTime":"2025-12-24 05:25","pubTimestamp":1766525100,"startTime":"0","endTime":"0","summary":"DENVER, Dec.  23, 2025  (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients faci","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/23/3210139/0/en/SeaStar-Medical-Announces-1-for-10-Reverse-Split.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCD"],"gpt_icon":0},{"id":"2589554843","title":"Vertex's Gene Therapy Works In Children With Blood Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2589554843","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589554843?lang=en_us&edition=fundamental","pubTime":"2025-12-08 21:18","pubTimestamp":1765199880,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Incorporated  on Saturday presented data from multiple studies demonstrating the clinical benefits of Casgevy  in patients aged 5 years and older with severe sickle cell disease  or transfusion-dependent beta thalassemia .SCD is a severe inherited blood disease that damages red blood cells, limits oxygen delivery, causes intense pain, and can shorten life.TDT is a life-threatening genetic condition that forces patients to rely on regular blood transfusions and lifelong treatment to remove excess iron.Also Read: FDA Fast-Tracks 6 More Drugs – Obesity And Cancer Drugs Included. In children with SCD, 11 patients have been dosed with Casgevy in the Phase 3 CLIMB-151 clinical study, and all (4/4) patients with sufficient follow-up achieved the primary endpoint of being free from vaso-occlusive crises  for at least 12 consecutive months .In children with TDT, 13 patients have been dosed with Casgevy in the Phase 3 CLIMB-141 clinical study, and all (6/6) patients with s","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/08/Vertex-Pharmaceuticals-Inc-.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/08/Vertex-Pharmaceuticals-Inc-.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/25/12/49254689/vertexs-gene-therapy-works-in-children-with-blood-disorders","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49254689/vertexs-gene-therapy-works-in-children-with-blood-disorders","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4567","SCD","BK4139","IE0002141913.USD","LU0289739699.SGD","LU1093756168.USD","LU1674673691.USD","LU0320765992.SGD","SG9999001176.SGD","IE00B2B36J28.USD","LU0109394709.USD","LU0432979614.USD","LU0058720904.USD","ASH","IE00BFTCPJ56.SGD","IE00B19Z3B42.SGD","LU1069344957.HKD","IE00B19Z9Z06.USD","LU2462157665.USD","IE0002270589.USD","LU0061475181.USD","LU0234570918.USD","LU1778281490.HKD","SG9999013999.USD","BK4532","LU0823416689.USD","LU2463526074.USD","LU0889565916.HKD","LU1815336091.USD","IE0009355771.USD","LU2417539215.USD","VERX","BK4588","LU0566484027.USD","IE00BJT1NW94.SGD","LU2362541513.USD","LU1674673428.USD","IE00B894F039.SGD","LU1585245621.USD","IE00B19Z9P08.USD","LU0417517546.SGD","LU2324357040.USD","LU0256863811.USD","LU1093756325.SGD","SG9999001176.USD","VRTX","LU2237438978.USD","IE00BJJMRZ35.SGD","IE00BZ9MQY76.HKD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2589156825","title":"Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2589156825","media":"GlobeNewswire","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589156825?lang=en_us&edition=fundamental","pubTime":"2025-12-06 21:00","pubTimestamp":1765026000,"startTime":"0","endTime":"0","summary":"Updated Data from 31 Adult and Adolescent SCD PatientsTreated with risto-cel (Formerly BEAM-101) Show Mean Hemoglobin F (HbF) Induction of >60%, Hemoglobin S (HbS) Reduction to <40%, and Resolution of","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/06/3201044/0/en/Beam-Therapeutics-Reports-Updated-Data-from-BEACON-Phase-1-2-Trial-of-ristoglogene-autogetemcel-risto-cel-Highlighting-Durable-Differentiated-Profile-in-Sickle-Cell-Disease-SCD-at-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4117","ASH","BK4107","LU2463526074.USD","BK4007","BK4109","BK4539","SCD","AFG","HSCT","LENZ"],"gpt_icon":0},{"id":"2588276055","title":"Fulcrum Therapeutics to Host Investor Event to Review New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease on December 7, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2588276055","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588276055?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:30","pubTimestamp":1764682200,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Dec.  02, 2025  (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/02/3197957/0/en/Fulcrum-Therapeutics-to-Host-Investor-Event-to-Review-New-Clinical-Data-from-the-PIONEER-trial-of-Pociredir-in-Sickle-Cell-Disease-on-December-7-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2463526074.USD","SCD","BK4181","BK4007","BK4585","BK4109","BK4588","BK4218","HST","ASH","FULC"],"gpt_icon":0},{"id":"2588552720","title":"SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI","url":"https://stock-news.laohu8.com/highlight/detail?id=2588552720","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588552720?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:27","pubTimestamp":1764682020,"startTime":"0","endTime":"0","summary":"FDA lowers surveillance requirement to 50 patients from 300 patients in original HDE approval based on assessment of first 21 SAVE Surveillance Registry patients Compelling efficacy data to date along","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/02/3197927/0/en/SeaStar-Medical-Announces-FDA-Approval-of-Reduction-in-Mandatory-Enrollment-for-SAVE-Surveillance-Registry-Evaluating-QUELIMMUNE-Safety-for-Pediatric-AKI.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SAVE","BK4008","BK4500","SCD"],"gpt_icon":0},{"id":"2588205807","title":"LMP Capital and Income Fund Declares November Distribution with Majority from Long-Term Capital Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2588205807","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588205807?lang=en_us&edition=fundamental","pubTime":"2025-12-01 21:01","pubTimestamp":1764594070,"startTime":"0","endTime":"0","summary":"LMP Capital and Income Fund Inc.  announced an estimated monthly distribution of $0.1200 per share to be paid on December 1, 2025. For the fiscal year-to-date as of October 31, 2025, total distributions per share are estimated at $1.2990, primarily sourced from net realized long-term capital gains.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LMP Capital and Income Fund Inc. published the original content used to generate this news brief via Business Wire  on December 01, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL4Qcc0c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCD"],"gpt_icon":0},{"id":"2588672039","title":"Press Release: LMP Capital and Income Fund Inc. (SCD or \"the Fund\"; CUSIP: 50208A102) Announces Notification of Sources of Distributions","url":"https://stock-news.laohu8.com/highlight/detail?id=2588672039","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588672039?lang=en_us&edition=fundamental","pubTime":"2025-12-01 21:00","pubTimestamp":1764594000,"startTime":"0","endTime":"0","summary":"Pursuant to Section 19 of the Investment Company Act of 1940. The Fund's estimated sources of the distribution to be paid on December 1, 2025, and for the fiscal year 2025 year-to-date are as follows:. Distribution  Net Investment  Short-Term Capital  Long-Term Capital  Return of. Cumulative Estimated Allocations fiscal year-to-date as of October 31, 2025, for the fiscal year ending November 30, 2025:. Distribution  Net Investment     Short-Term       Long-Term Capital  Return of. change in net         Annualized       relation to the       Year-To-Date. asset value    Distribution Rate   change in NAV for   Distribution Rate. for the 5- year     (as a percentage   the fiscal period    (as a percentage. period ended on       of NAV as of          through           of NAV as of","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCD","NAV"],"gpt_icon":0},{"id":"2585658461","title":"Press Release: BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2585658461","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585658461?lang=en_us&edition=fundamental","pubTime":"2025-11-24 20:00","pubTimestamp":1763985600,"startTime":"0","endTime":"0","summary":"- Establishes joint venture with Hemispherian AS to advance GLIX1, a first-in-class, oral, small molecule targeting DNA damage response in glioblastoma and other cancers -. - Phase 1/2a clinical trial of GLIX1 expected to commence in Q1 2026 -. - Management to host conference call today, November 24 , at 8:30 am EST -. TEL AVIV, Israel, Nov. 24, 2025 /PRNewswire/ -- BioLineRx Ltd.  , a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its unaudited financial results for the quarter ended September 30, 2025, and provided a corporate update.\"At the same time, the ongoing CheMo4METPANC Phase 2b clinical trial of motixafortide in metastatic pancreatic cancer, which is being led by Columbia University and supported by both Regeneron and BioLineRx, continues to progress, giving us a second opportunity to leverage our drug development expertise to bring true innovation to patients with difficult-to-treat cancers,\" Mr. Se","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCD","LU1093756325.SGD","MTD","PFS","LU0347712357.USD","BK4139","BK4548","LU2413666426.HKD","LU1721428933.USD","BK4567","BK4195","BK4588","BK4585","IE00B64QTZ34.USD","IE00BLDYK493.USD","LU2211817866.USD","BK4533","IE00BFXG0V08.USD","BK4121","LU2413666699.HKD","BLRX","BK4211","BK4109","IE00BYQQ9H92.USD","LU2463526074.USD","ASH","LU1093756168.USD","PB"],"gpt_icon":0},{"id":"2584158708","title":"SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2584158708","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584158708?lang=en_us&edition=fundamental","pubTime":"2025-11-20 22:52","pubTimestamp":1763650320,"startTime":"0","endTime":"0","summary":"DENVER, Nov.  20, 2025  (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients faci","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/20/3192079/0/en/SeaStar-Medical-to-Present-at-Upcoming-NobleCon21-Investor-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCD"],"gpt_icon":0},{"id":"2584298806","title":"Press Release: SeaStar Medical Announces Appointment of Michael Messinger as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2584298806","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584298806?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:43","pubTimestamp":1763386980,"startTime":"0","endTime":"0","summary":"DENVER, Nov. 17, 2025  -- SeaStar Medical Holding Corporation , a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that Michael Messinger, a seasoned healthcare executive with over 25 years of industry experience, has joined SeaStar Medical as Chief Financial Officer.SeaStar Medical is a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life. The QUELIMMUNE  therapy is SeaStar Medical's first commercial product based on its patented Selective Cytopheretic Device  technology. The QUELIMMUNE  therapy was approved in 2024 by the U.S. Food and Drug Administration . It is the only FDA approved product for the ultra-rare condition of life-threatening acute kidney injury  due to sepsis or a septic condition in critically ill pediatric patients. SeaStar Medical's Selective Cytopheretic Devi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","SCD","ICU"],"gpt_icon":0},{"id":"2583917681","title":"Press Release: Emmaus Life Sciences Reports Quarterly Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2583917681","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583917681?lang=en_us&edition=fundamental","pubTime":"2025-11-15 04:57","pubTimestamp":1763153820,"startTime":"0","endTime":"0","summary":"\"We experienced a 38% decline in net revenues for the three months ended September 30, 2025 as compared to the same period in 2024 due to ongoing competition from generic L-Glutamine in the U.S. and lower sales in the Middle East North Africa, or MENA, region,\" commented Willis Lee, Chairman and Chief Executive Officer of Emmaus. \"We realized income from operations of $0.7 million compared to $0.8 million in the prior year, partially offset by a 43% reduction in operating expenses,\" he added.Net Revenues. Net revenues for the three months ended September 30, 2025 were $3.4 million, compared to $5.5 million in the same period in 2024. The decrease was due to a decrease in U.S. sales which management attributes to competition from the generic version of L-Glutamine introduced in the market in mid-2024 and a decrease of sales in the MENA region, which management attributes to the timing of sales in the region.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","SCD","BK4232","BK4022","BK4007","EMMA"],"gpt_icon":0},{"id":"2583514993","title":"SeaStar Medical Reports Third Quarter 2025 Financial Results and  Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2583514993","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583514993?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:05","pubTimestamp":1763067900,"startTime":"0","endTime":"0","summary":"Business highlights include: Three new top-rated children’s hospitals adopt QUELIMMUNE therapy for ultra-rare pediatric Acute Kidney Injury (AKI)Commercial use of QUELIMMUNE therapy demonstrates posit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/13/3187818/0/en/SeaStar-Medical-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZL793.SGD","IE00B66KJ199.SGD","LU2065731478.USD","SCD","IE0031619046.USD","BK4187","CRS","LU0963586101.USD","BK4006","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"2582872883","title":"CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2582872883","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582872883?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:00","pubTimestamp":1762779600,"startTime":"0","endTime":"0","summary":"-Positive Phase 1 data for CTX310 presented in a late-breaking presentation at the American Heart Association (AHA) Scientific Sessions and simultaneously published in The New England Journal of Medic","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/10/3184507/0/en/CRISPR-Therapeutics-Provides-Business-Update-and-Reports-Third-Quarter-2025-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417517546.SGD","BK4588","LU0942090050.USD","LU0889565916.HKD","LU1430594728.SGD","SLE","VERX","LU2324357040.USD","AHP","LU2463526074.USD","LU1778281490.HKD","LU2237438978.USD","IE00BZ9MQY76.HKD","BK4149","FXI","ASH","IE0009355771.USD","TG","LDL","BK4109","LU0432979614.USD","BK4153","CAR","LU1674673691.USD","CAT","IE00B2B36J28.USD","UAE","LU1674673428.USD","LU2236285917.USD","LU0963586101.USD","BK4597","LU0566484027.USD","LU1861559042.SGD","LU0079474960.USD","BK4230","LU1559883803.SGD","KSA","LU1585245621.USD","LU1917777945.USD","LU2362540622.SGD","VRTX","LU1988902786.USD","SCD","LU2456880835.USD","CRSP","LU0234570918.USD","MACE","IE00B19Z3581.USD","LU1035775433.USD","LU0061475181.USD"],"gpt_icon":0},{"id":"2581779122","title":"SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2581779122","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581779122?lang=en_us&edition=fundamental","pubTime":"2025-11-05 23:03","pubTimestamp":1762354980,"startTime":"0","endTime":"0","summary":"DENVER, Nov.  05, 2025  (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients faci","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/05/3181646/0/en/SeaStar-Medical-to-Report-Third-Quarter-Financial-Results-on-November-13-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCD"],"gpt_icon":0},{"id":"2580219131","title":"Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition","url":"https://stock-news.laohu8.com/highlight/detail?id=2580219131","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580219131?lang=en_us&edition=fundamental","pubTime":"2025-11-03 22:01","pubTimestamp":1762178460,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Nov.  03, 2025  (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients w","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/03/3179391/31990/en/Agios-to-Present-New-Mitapivat-Data-in-Rare-Blood-Disorders-at-67th-ASH-Annual-Meeting-and-Exposition.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PK","ASH","BK4181","SCD","LU2463526074.USD","BK4218","BK4109"],"gpt_icon":0},{"id":"2580557213","title":"Press Release: LMP Capital and Income Fund Inc. (SCD or \"the Fund\"; CUSIP: 50208A102) Announces Notification of Sources of Distributions","url":"https://stock-news.laohu8.com/highlight/detail?id=2580557213","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580557213?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:00","pubTimestamp":1762174800,"startTime":"0","endTime":"0","summary":"Pursuant to Section 19 of the Investment Company Act of 1940. The Fund's estimated sources of the distribution to be paid November 3, 2025, and for the fiscal year 2025 year-to-date are as follows:. Cumulative Estimated Allocations fiscal year-to-date as of September 30, 2025, for the fiscal year ending November 30, 2025:. change in net        Annualized        relation to the      Year-To-Date. asset value    Distribution Rate   change in NAV for   Distribution Rate. for the 5-year     (as a percentage    the fiscal period   (as a perce","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAV","SCD"],"gpt_icon":0},{"id":"2579771579","title":"Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2579771579","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579771579?lang=en_us&edition=fundamental","pubTime":"2025-10-29 19:00","pubTimestamp":1761735600,"startTime":"0","endTime":"0","summary":"― Announced encouraging results in July 2025 from the 12 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD) ― ― Enrollment complete in the 20 mg dose cohort (n=12) ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/29/3176248/0/en/Fulcrum-Therapeutics-Announces-Recent-Business-Highlights-and-Financial-Results-for-Third-Quarter-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASH","BK4213","BK4109","VOC","FULC","DBA","SCD","BK4007","LU2463526074.USD"],"gpt_icon":0},{"id":"2572438536","title":"LMP Capital and Income Fund Inc. Releases Notification of Sources of Distributions Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2572438536","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572438536?lang=en_us&edition=fundamental","pubTime":"2025-10-01 20:01","pubTimestamp":1759320060,"startTime":"0","endTime":"0","summary":"LMP Capital and Income Fund Inc.  has released its latest distribution report for the fiscal year 2025. For the September monthly distribution, the fund announced a per-share payout of $0.12, with approximately 9.4% derived from net investment income and 90.6% from net realized long-term capital gains. Year-to-date, the fund has distributed $1.059 per share, with the majority coming from long-term capital gains. The fund noted that these figures are estimates and subject to change.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LMP Capital and Income Fund Inc. published the original content used to generate this news brief via Business Wire  on October 01, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDLb7Yv1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCD"],"gpt_icon":0},{"id":"2571336601","title":"SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children","url":"https://stock-news.laohu8.com/highlight/detail?id=2571336601","media":"GlobeNewswire","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571336601?lang=en_us&edition=fundamental","pubTime":"2025-09-29 20:36","pubTimestamp":1759149360,"startTime":"0","endTime":"0","summary":"Data show results consistent with clinical trial experienceA high level of safety – no device-related adverse eventsStrong survival data extending to 90 days DENVER, Sept.  29, 2025  (GLOBE NEWSWIRE) ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/29/3157736/0/en/SeaStar-Medical-Reports-Positive-Early-Results-for-QUELIMMUNE-Therapy-in-Pediatric-Acute-Kidney-Injury-AKI-at-the-5th-International-Symposium-on-Acute-Kidney-Injury-in-Children.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":40,"code":"91000000","status":"200"}]}}